Daicel Corporation 9DC.SG Stock
Daicel Corporation Price Chart
Daicel Corporation 9DC.SG Financial and Trading Overview
Daicel Corporation stock price | 8.85 EUR |
Previous Close | 8.35 EUR |
Open | 8.2 EUR |
Bid | 8.2 EUR x 100000 |
Ask | 8.4 EUR x 100000 |
Day's Range | 8.2 - 8.2 EUR |
52 Week Range | 5.6 - 8.45 EUR |
Volume | 0 EUR |
Avg. Volume | 31 EUR |
Market Cap | 2.39B EUR |
Beta (5Y Monthly) | 0.633333 |
PE Ratio (TTM) | 9.5348835 |
EPS (TTM) | 1.18 EUR |
Forward Dividend & Yield | 0.3 (3.59%) |
Ex-Dividend Date | September 28, 2023 |
1y Target Est | N/A |
9DC.SG Valuation Measures
Enterprise Value | 241.63B EUR |
Trailing P/E | 9.5348835 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.0044340803 |
Price/Book (mrq) | 0.007934112 |
Enterprise Value/Revenue | 0.449 |
Enterprise Value/EBITDA | 3.055 |
Trading Information
Daicel Corporation Stock Price History
Beta (5Y Monthly) | 0.633333 |
52-Week Change | 42.01% |
S&P500 52-Week Change | 20.43% |
52 Week High | 8.45 EUR |
52 Week Low | 5.6 EUR |
50-Day Moving Average | 7.35 EUR |
200-Day Moving Average | 6.67 EUR |
9DC.SG Share Statistics
Avg. Volume (3 month) | 31 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 287.72M |
Float | 271.3M |
Short Ratio | N/A |
% Held by Insiders | 5.30% |
% Held by Institutions | 56.47% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 38 |
Trailing Annual Dividend Yield | 455.08% |
5 Year Average Dividend Yield | 364.00% |
Payout Ratio | 0.285 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 7.56% |
Operating Margin (ttm) | 8.83% |
Gross Margin | 27.10% |
EBITDA Margin | 14.69% |
Management Effectiveness
Return on Assets (ttm) | 4.05% |
Return on Equity (ttm) | 14.11% |
Income Statement
Revenue (ttm) | 538.03B EUR |
Revenue Per Share (ttm) | 1836.54 EUR |
Quarterly Revenue Growth (yoy) | 6.80% |
Gross Profit (ttm) | N/A |
EBITDA | 79.08B EUR |
Net Income Avi to Common (ttm) | 40.68B EUR |
Diluted EPS (ttm) | 0.86 |
Quarterly Earnings Growth (yoy) | 43.60% |
Balance Sheet
Total Cash (mrq) | 93.84B EUR |
Total Cash Per Share (mrq) | 328.53 EUR |
Total Debt (mrq) | 317.83B EUR |
Total Debt/Equity (mrq) | 102.38 EUR |
Current Ratio (mrq) | 1.841 |
Book Value Per Share (mrq) | 1033.512 |
Cash Flow Statement
Operating Cash Flow (ttm) | 26.85B EUR |
Levered Free Cash Flow (ttm) | -32196499456 EUR |
Profile of Daicel Corporation
Country | Germany |
State | N/A |
City | Osaka |
Address | Grand Front Osaka Tower-B |
ZIP | 530-0011 |
Phone | 81 6 7639 7171 |
Website | https://www.daicel.com |
Industry | Specialty Chemicals |
Sector(s) | Basic Materials |
Full Time Employees | N/A |
Daicel Corporation engages in the medical/healthcare, smart, safety, materials, engineering plastics, and other businesses in Japan, China, and internationally. The company offers 1,3-Butylene glycol and polyglycerin for cosmetics; chiral and achiral columns/stationary phases, analytical tools, analytical/purification/synthesis/formulation services, chiral and bio reagents, analytical standards, and DNA and RNA-based probes; triacetylcellulose, high performance film, solvent for electronic materials, polymer for resist, semiconductor process cleaning agent, optical parts and lens unit, silver nanoparticle ink, and organic semiconductor devices; and inflators, pyro-fuse, and safety device for non-mobility products; and acetic acid and derivatives, cellulose acetate, acetate tow, cycloaliphatic epoxies, caprolactone, ketene derivatives, and alkylamines. It also provides ceramide derived from konjac root, equol derived from soybeans, ß-cryptoxanthin derived from citrus unshiu, and lactobionic acid derived from milk; DiSPERZiSTA, a dispersible filler for dietary supplement tablet; and MOiSTCARM, a make granules easy to swallow. In addition, the company offers engineering plastics and plastic compound products, high performance polymer, functional sheets, formed trays, and packaging films; water treatment systems and diffusers, such as UF membrane modules, ultra-fine bubble membrane diffusers, and E mizu showers. Its products are used in transportation, electronics, medical care, personal care, everyday life, and environment and energy applications. The company was formerly known as Daicel Chemical Industries, Ltd. and changed its name to Daicel Corporation in October 2011. Daicel Corporation was incorporated in 1919 and is headquartered in Osaka, Japan.
Q&A For Daicel Corporation Stock
What is a current 9DC.SG stock price?
Daicel Corporation 9DC.SG stock price today per share is 8.85 EUR.
How to purchase Daicel Corporation stock?
You can buy 9DC.SG shares on the Stuttgart exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Daicel Corporation?
The stock symbol or ticker of Daicel Corporation is 9DC.SG.
Which industry does the Daicel Corporation company belong to?
The Daicel Corporation industry is Specialty Chemicals.
How many shares does Daicel Corporation have in circulation?
The max supply of Daicel Corporation shares is 278.79M.
What is Daicel Corporation Price to Earnings Ratio (PE Ratio)?
Daicel Corporation PE Ratio is 7.50000050 now.
What was Daicel Corporation earnings per share over the trailing 12 months (TTM)?
Daicel Corporation EPS is 1.18 EUR over the trailing 12 months.
Which sector does the Daicel Corporation company belong to?
The Daicel Corporation sector is Basic Materials.